This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Using Raman for the characterization of nasal drug suspension products
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions
The New Imperative
Publications, Pharmaceutical, Drug Delivery Innovations, Market Insights, Product Solutions, Innovation & Insights
Case Study – Pre-Clinical Respiratory Research with PADA
Case Studies, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Intranasal Immunization: Promises and Challenges
Webinars, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Innovation & Insights, Drug Delivery Innovations
